Method for improving disease diagnosis using measured analytes
A disease and a technology for diagnosing diseases, applied in the field of diagnostic testing, can solve problems such as non-biological relevance, non-correlation, difficulty in algorithm training, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0133] Example 1 : Clinical Study - Evaluation of Blood Tests for Breast Cancer
[0134] OTraces BC Sera Dx Test Kit and OTraces CDx Immunochemistry Instrumentation System ( www.otraces.com ) properties to assess the risk of the presence of breast cancer. The test kit measures the concentrations of five very low-level cytokines and tissue markers and uses the training set model developed as described above to calculate the scores CS1 and CSq for the assessment of breast cancer risk. The proteins measured were IL-6, IL-8, VEGF, TNFα and PSA. The experiment, which included measuring approximately 300 patient samples, was divided into approximately 50% breast cancer cases diagnosed by biopsy, and 50% patients presumed to have no disease (or in this case, no breast cancer). In this group, the biopsy results of 200 samples were precisely divided into 50% non-disease and 50% with breast cancer disease, and each group was subdivided into specific age groups.
[0135] The sample...
example 2
[0145] Example 2 : Improving diagnostic accuracy using the metavariable 'age'.
[0146] Table 2 shows the statistical results of the clinical study for 868 samples of breast cancer subjects. Table 3 shows a comparison of various methods for correlation calculations. The standard method, logistic regression, only showed 82% predictive power. Standard proximity cluster analysis improved this, yielding about 88% predictive power. The method described in the specification yields greater than 97% predictive power using metavariables and weighting methods, topological stability adjustments, immune system response groupings and weighted adjustments for assay performance, combined with blinded instability testing and inconsistency Algorithm correction.
example 3
[0147] Example 3 : Improving Diagnostic Accuracy in Ovarian Cancer Research Using the Metavariable 'Age'.
[0148] Table 4 shows the results of a study of 107 women with or without ovarian cancer using the metavariable approach described herein. This study did not use all of the improvements in predictive power described in this specification, but still achieved a relatively superior predictive power of about 95%.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


